In the article titled ‘Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance’, published in the September issue of Expert Opinion on Pharmacotherapy (Expert Opin Pharmacother 2012:13(12):2027-36 [doi:10.1517/14656566.2012.719876]), the following errors occurred:
Page 2028, line 112: “bipolar depression” should have read “bipolar disorder”
For the maintenance treatment of patients with bipolar disorder, aripiprazole is one of the recommended first-line options [11].
Page 2029, line 219: “major depressive episodes” should have read “bipolar depression”
Although aripiprazole has been approved for acute treatment of manic episodes, evidence to date does not support its efficacy in the treatment of bipolar depression and in the prevention of depressive relapses [27,28].
Informa Healthcare apologises for any inconvenience caused.